News & Perspective

Mar 19, 2012

Mar 19, 2012

Moderate flu activity persists in parts of US, world

(CIDRAP News) – Influenza activity remained elevated in Midwestern US states but elsewhere was at low levels, while some Northern Hemisphere countries reported moderate flu activity, according to the latest US and international reports.

Feb 17, 2012

Feb 17, 2012

Flu activity continues late-season climb

(CIDRAP News) – Flu activity in the United States, Canada, and parts of Europe continues to increase, but for the most part, levels of both mild and severe illness are low compared with past flu seasons, the World Health Organization (WHO) said today.

Activity appears to have peaked in a few Northern Hemisphere locations, such as some countries in Western Europe, North Africa, and northern China, according to the WHO.

Feb 03, 2012

Feb 03, 2012

Flu continues late-season Northern Hemisphere push

(CIDRAP News) – Flu activity in many Northern Hemisphere countries continued its late-season rise last week, with areas such as the United States, Canada, and Europe reporting steady increases.

Though flu activity overall is low, notable increases are occurring in North America, western Europe, and northern China, the World Health Organization (WHO) said today.

May 14, 2010

May 14, 2010

Surveillance reports show few pandemic flu hot spots

(CIDRAP News) – Low levels of flu activity across the United States resemble a summer pattern, while globally only sporadic pandemic flu activity is occurring with the most active areas in parts of the Caribbean and Central America, according to updates today.

Nov 15, 2007

Nov 15, 2007

THE PANDEMIC VACCINE PUZZLE Can we vaccinate enough people in time to matter?

Maryn McKennaContributing Writer

(CIDRAP News) – This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»